GKWIM
TWST icon

Gerber Kawasaki Wealth & Investment Management’s Twist Bioscience TWST Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-655
Closed -$70K – 1045
2021
Q3 		$70K Buy
+655
New +$75K 0.01% 278

Other funds holding TWST

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's TWST Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Twist Bioscience (TWST) in Q4 2021, closing a stake of 655 shares — an estimated $70K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in TWST in Q3 2021 and held it in 1 quarter. The position peaked at $70K in Q3 2021. 237 funds tracked by Wall St. Rank hold TWST as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Twist Bioscience position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 655 Twist Bioscience shares in Q4 2021, an estimated $70K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Twist Bioscience in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's Twist Bioscience position peaked at $70K in Q3 2021.
  • 237 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.